Skip to main content
. 2020 Oct 13;295(50):17241–17250. doi: 10.1074/jbc.RA120.015757

Figure 6.

Figure 6.

LukE DR1 is sufficient for Darc targeting in vivo. A, survival curve of Swiss Webster mice (females, 4–6 weeks old) challenged with IV purified toxin (n = 3–5 mice/group). B and C, survival curve of B6 WT (B) and Darc−/− (C) mice (mixed males and females, 7–10 weeks old) injected with purified toxin via retro-orbital injection (n = 4–6 mice/group). LukSE-DR1 indicates LukS-PV with the DR1 from LukE. SD indicates LukS-PV + LukD. The data are pooled from 2–3 independent experiments. **, p < 0.01; *, p < 0.05. A and B, Mantel–Cox test.